etoposide has been researched along with Inflammation in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (10.00) | 18.7374 |
| 1990's | 3 (10.00) | 18.2507 |
| 2000's | 6 (20.00) | 29.6817 |
| 2010's | 8 (26.67) | 24.3611 |
| 2020's | 10 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
| Askari, K; Ghalebandi, S; Haghparast, A; Mousavi, Z; Zareie, F | 1 |
| Huang, Y; Jiang, L; Jin, Y; Ma, X; Wang, Y; Yu, W | 1 |
| Borok, M; Bukuru, A; Busakhala, N; Campbell, TB; Chang, D; Epeldegui, M; Godfrey, C; Hoagland, B; Hosseinipour, MC; Kang, M; Kanyama, C; Krown, SE; Langat, D; Lee, J; Magpantay, LI; Martínez-Maza, O; Mngqibisa, R; Mwelase, N; Nyirenda, M; Samaneka, W | 1 |
| Arnold, R; Djabali, K; Henriques, G; Liu, C | 1 |
| Li, Y; Li, Z; Wang, Y; Xu, R; Xu, W; Zhu, X | 1 |
| Loscocco, GG | 1 |
| Beretta, L; Berkers, CR; Bonte-Mineur, F; Chouri, E; Cossu, M; Gulersonmez, C; Hoekstra, AT; Marut, W; Ottria, A; Radstake, TRDJ; Rossato, M; Stigter, E; Tieland, RG; van der Kroef, M; Vazirpanah, N; Wichers, CGK; Zimmermann, M | 1 |
| Araki, M; Iwata, T; Maruyama, Y; Mitsui, Y; Nasu, Y; Sadahira, T; Wada, K; Watanabe, T; Yoshinaga, K | 1 |
| Beltrán, B; Castillo, JJ; Castro, D; Huerta, Y; Lalupu, K; Mendoza, R; Pachas, C; Quiñones, MDP | 1 |
| Allen, SW; Barnum, JL; Canna, SW; Daley, JD; Gumus, S; Reyes-Mugica, M; Salgado, CM; Schneider, C; Segal, JE; Thakrar, D | 1 |
| Al-Otaibi, A; Alabbas, F; Alhumaidan, W; Ali, TB; Elyamany, G | 1 |
| Aoyagi, T; Kaku, M; Kawakami, K; Oshima, K; Sato, Y; Toyama, M | 1 |
| Blijlevens, NM; de Haan, AF; Donnelly, JP; Herbers, AH; van der Velden, WJ | 1 |
| Fu, M; Huang, S; Miao, R; Niu, J; Shi, Y; Wang, T; Wu, J; Wu, ZH; Xue, J | 1 |
| Barco, A; Galea, E; Giménez-Llort, L; Giralt, M; Golbano, A; Hidalgo, J; Jia, P; Jové, M; Masgrau, R; Pardo, L; Portero-Otin, M; Pujol, A; Ruiz, M; Schlüter, A; Valor, LM; Zhao, Z | 1 |
| Honkakoski, P; Hytti, M; Kaarniranta, K; Kauppinen, A; Korhonen, E; Lahtela-Kakkonen, M; Määttä, E; Piippo, N; Suuronen, T; Tokarz, P | 1 |
| Avila, DN; Bishop, MR; Bryant, KE; Danforth, DN; Fowler, DH; Gea-Banacloche, J; Gress, RE; Hardy, NM; Krumlauf, MC; Liewehr, DJ; Pavletic, S; Sportès, C; Steinberg, SM | 1 |
| Chang, WJ; Chou, HY; Li, TK; Shen, TL; Tai, PH; Yang, YC | 1 |
| Bain, BJ; Chakravorty, S; Coulter, C; Johnston, R | 1 |
| Awan, F; Devine, S; Hamadani, M | 1 |
| Enomoto, R; Hirano, H; Hosoda, A; Lee, E; Nagase, I; Sugahara, C; Suzuki, C; Takamura, Y; Yokoi, T; Yoshikawa, A | 1 |
| Dimitrova, P; Remichkova, M; Yordanov, M | 1 |
| Bodey, GP; Cabanillas, F; Freireich, EJ; Hagemeister, FB | 1 |
| Beijnen, JH; Borst, P; Evers, R; Krimpenfort, P; Mayer, U; Mol, CA; van der Valk, M; van Leusden, MR; Wijnholds, J; Zaman, GJ | 1 |
| Belhadj, K; Maubec, E; Oberlin, O; Roujeau, JC | 1 |
| Abbadessa, V; Avanzini, P; Carotenuto, M; Cavanna, L; Federico, M; Gobbi, PG; Leone, G; Lombardo, M; Moretti, G; Pitini, V | 1 |
| Gradishar, WJ; Kies, MS; Vokes, EE | 1 |
| Banham, SW; Milroy, R; Shapiro, D; Shenkin, A | 1 |
| Leijh, PC; Linde, I; van Furth, R; van't Wout, JW | 1 |
2 trial(s) available for etoposide and Inflammation
| Article | Year |
|---|---|
Strategies to improve long-term outcome in stage IIIB inflammatory breast cancer: multimodality treatment including dose-intensive induction and high-dose chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Inflammation; Melphalan; Middle Aged; Remission Induction; Survival Analysis; Treatment Outcome | 2009 |
ProMACE-cytaBOM versus MACOP-B in intermediate and high grade NHL. Preliminary results of a prospective randomized trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hematopoiesis; Humans; Inflammation; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mucous Membrane; Prednisolone; Prednisone; Prognosis; Prospective Studies; Survival Analysis; Vincristine | 1991 |
28 other study(ies) available for etoposide and Inflammation
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |
Orexin receptors in the CA1 region of hippocampus modulate the stress-induced antinociceptive responses in an animal model of persistent inflammatory pain.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzoxazoles; CA1 Region, Hippocampal; Cyclophosphamide; Disease Models, Animal; Doxorubicin; Etoposide; Inflammation; Isoquinolines; Male; Microinjections; Naphthyridines; Orexin Receptor Antagonists; Orexin Receptors; Pain; Pain Measurement; Prednisone; Pyridines; Rats, Wistar; Stress, Psychological; Urea; Vincristine | 2022 |
lncRNA PRR34-AS1 knockdown represses neuroinflammation and neuronal death in traumatic brain injury by inhibiting microRNA-498 expression.
Topics: Animals; Apoptosis; Brain Injuries, Traumatic; Cell Proliferation; Etoposide; Inflammation; Mice; MicroRNAs; Neuroinflammatory Diseases; RNA, Long Noncoding | 2023 |
Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings.
Topics: Acquired Immunodeficiency Syndrome; Biomarkers; Chemoradiotherapy; Etoposide; HIV Infections; Humans; Inflammation; Interleukin-10; Ligands; Matrix Metalloproteinase 2; Receptors, Tumor Necrosis Factor; Resource-Limited Settings; Sarcoma, Kaposi; Vascular Endothelial Growth Factor A | 2023 |
Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells.
Topics: Adenosine Triphosphate; Alopecia; Arthritis; Autophagy; Azetidines; Blotting, Western; Cell Cycle; Cells, Cultured; Cellular Senescence; Child; Child, Preschool; Data Mining; Etoposide; Female; Humans; Immunohistochemistry; Inflammation; Janus Kinase 1; Janus Kinase 2; Lamin Type A; Lipodystrophy; Male; Mutation; Progeria; Purines; Pyrazoles; Reactive Oxygen Species; STAT1 Transcription Factor; STAT3 Transcription Factor; Sulfonamides; Vascular Diseases | 2019 |
MicroRNA-23a-3p improves traumatic brain injury through modulating the neurological apoptosis and inflammation response in mice.
Topics: Animals; Apoptosis; Base Sequence; Brain Injuries, Traumatic; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Down-Regulation; Etoposide; Inflammation; Male; Mice, Inbred C57BL; MicroRNAs; Models, Biological; Neurons; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Signal Transduction; TOR Serine-Threonine Kinases; Up-Regulation | 2020 |
Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Etoposide; Humans; Inflammation; Lymphocyte Activation; Lymphohistiocytosis, Hemophagocytic; Pandemics; Pneumonia, Viral; SARS-CoV-2; T-Lymphocytes, Cytotoxic; Topoisomerase II Inhibitors | 2020 |
Fatty Acid and Carnitine Metabolism Are Dysregulated in Systemic Sclerosis Patients.
Topics: Adult; Aged; Carnitine; Cohort Studies; Cytokines; Dendritic Cells; Etoposide; Fatty Acids; Female; Fibrosis; Gene Expression; Humans; Inflammation; Male; Metabolome; Metabolomics; Middle Aged; Organic Cation Transport Proteins; Oxidation-Reduction; Scleroderma, Systemic; Signal Transduction | 2020 |
Comparison of inflammation-based prognostic scores as predictors of survival outcomes in patients with germ cell tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bleomycin; C-Reactive Protein; Cisplatin; Etoposide; Humans; Inflammation; Kaplan-Meier Estimate; Lymphocyte Count; Male; Middle Aged; Neutrophils; Platelet Count; Prognosis; Progression-Free Survival; Retrospective Studies; ROC Curve; Seminoma; Serum Albumin; Serum Globulins; Survival Rate; Testicular Neoplasms; Young Adult | 2021 |
Clinical, inflammatory and immunohistochemical features in a cohort of Peruvian patients with diffuse large B-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cohort Studies; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Immunohistochemistry; Inflammation; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Peru; Prednisone; Prognosis; Progression-Free Survival; Retrospective Studies; Risk Factors; Rituximab; Treatment Outcome; Vincristine | 2021 |
Systemic and Nodular Hyperinflammation in a Patient with Refractory Familial Hemophagocytic Lymphohistiocytosis 2.
Topics: Alemtuzumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Neutralizing; Dexamethasone; Etoposide; Fatal Outcome; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Infant; Inflammation; Interleukin 1 Receptor Antagonist Protein; Lymphohistiocytosis, Hemophagocytic; Perforin; Salvage Therapy | 2021 |
Familial hemophagocytic lymphohistiocytosis induced by SARS-CoV-2.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Child; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Etoposide; Female; Humans; Immunosuppressive Agents; Inflammation; Interleukin 1 Receptor Antagonist Protein; Lymphohistiocytosis, Hemophagocytic; SARS-CoV-2 | 2021 |
Etoposide and Corticosteroid Combination Therapy Improves Acute Respiratory Distress Syndrome in Mice.
Topics: Animals; Disease Models, Animal; Drug Combinations; Etoposide; Inflammation; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred C57BL; Prednisolone; Respiratory Distress Syndrome | 2019 |
Impact of palifermin on intestinal mucositis of HSCT recipients after BEAM.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; C-Reactive Protein; Carmustine; Case-Control Studies; Cytarabine; Etoposide; Febrile Neutropenia; Female; Fibroblast Growth Factor 7; Hematopoietic Stem Cell Transplantation; Humans; Inflammation; Intestinal Mucosa; Male; Melphalan; Middle Aged; Mucositis; Neutropenia; Young Adult | 2014 |
USP10 inhibits genotoxic NF-κB activation by MCPIP1-facilitated deubiquitination of NEMO.
Topics: Animals; Apoptosis; Cytokines; DNA Damage; Etoposide; HEK293 Cells; Humans; I-kappa B Kinase; Inflammation; Mice; Mice, Mutant Strains; NF-kappa B; Ribonucleases; Signal Transduction; Transcription Factors; Ubiquitin; Ubiquitin Thiolesterase; Ubiquitination | 2013 |
Targeted activation of CREB in reactive astrocytes is neuroprotective in focal acute cortical injury.
Topics: Animals; Arabidopsis Proteins; Astrocytes; Brain Injuries; Cells, Cultured; CREB-Binding Protein; Disease Models, Animal; Etoposide; Female; Gene Expression Profiling; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Inflammation; Male; Meta-Analysis as Topic; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria; Molecular Chaperones; Neurofilament Proteins | 2016 |
Inhibition of BET bromodomains alleviates inflammation in human RPE cells.
Topics: Anti-Inflammatory Agents; Azabicyclo Compounds; Azepines; Benzodiazepines; Carbazoles; Cell Line; Cell Survival; Epithelial Cells; Etoposide; Gene Expression Regulation; Humans; Inflammation; Interleukin-6; Interleukin-8; Models, Biological; NF-kappa B; Protein Domains; Pyridines; Retinal Pigment Epithelium; RNA, Small Interfering; Signal Transduction; Sirtuin 1; Topoisomerase II Inhibitors; Transcription Factors; Triazoles; Tumor Suppressor Protein p53 | 2016 |
Topoisomerase II-mediated DNA cleavage and mutagenesis activated by nitric oxide underlie the inflammation-associated tumorigenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cell Line; Cell Transformation, Neoplastic; Coculture Techniques; DNA Cleavage; DNA Topoisomerases, Type II; Etoposide; HCT116 Cells; HL-60 Cells; Humans; Inflammation; Mice; Mice, Knockout; Mutagenesis; Nitric Oxide; Nitric Oxide Donors; Pyridines; S-Nitrosoglutathione | 2013 |
Teaching cases from the Royal Marsden and St Mary's Hospitals, case 26: refractory microcytic anaemia.
Topics: Anemia, Refractory; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Blood Sedimentation; C-Reactive Protein; Chlorambucil; Cough; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Inflammation; Male; Middle Aged; Prednisolone; Procarbazine; Remission Induction; Splenomegaly; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vinblastine; Vincristine | 2004 |
Paraneoplastic Sweet's syndrome and the pathergy phenomenon.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Diagnosis, Differential; Drug Eruptions; Etoposide; Female; Humans; Inflammation; Leukemia, Monocytic, Acute; Middle Aged; Mitoxantrone; Neutropenia; Paraneoplastic Syndromes; Sweet Syndrome | 2007 |
Wogonin prevents glucocorticoid-induced thymocyte apoptosis without diminishing its anti-inflammatory action.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Biological Transport; Dexamethasone; DNA Fragmentation; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Edema; Etoposide; Flavanones; Glucocorticoids; Immunosuppression Therapy; In Vitro Techniques; Inflammation; Male; Phosphatidylserines; Rats; Rats, Sprague-Dawley; Scutellaria baicalensis; Thymus Gland | 2007 |
Etoposide attenuates zymosan-induced shock in mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Etoposide; Inflammation; Liver; Macrophages; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Mice, SCID; Organ Size; Sepsis; Shock; Tumor Necrosis Factor-alpha; Zymosan | 2008 |
IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Inflammation; Lymphoma; Methotrexate; Mucous Membrane; Neutropenia; Podophyllotoxin; Recurrence | 1982 |
Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein.
Topics: Adult; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP-Binding Cassette Transporters; Bone Marrow Cells; Carrier Proteins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Humans; Inflammation; Leukotriene C4; Membrane Transport Proteins; Mice; Mice, Knockout; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Neoplasms, Experimental; Tumor Cells, Cultured | 1997 |
[Subcutaneous inflammatory edema induced by MINE chemotherapy].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Capillary Leak Syndrome; Creatine Kinase; Edema; Etoposide; Fat Necrosis; Female; Hodgkin Disease; Humans; Ifosfamide; Inflammation; Magnetic Resonance Imaging; Male; Mitoguazone; Pain; Recurrence; Vinblastine | 2001 |
Phase II trial of etoposide and doxorubicin in advanced head and neck cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Head and Neck Neoplasms; Humans; Inflammation; Leukocyte Count; Leukopenia; Mucous Membrane; Platelet Count; Remission Induction; Thrombocytopenia | 1990 |
Acute phase reaction during chemotherapy in small cell lung cancer.
Topics: Acute-Phase Reaction; Antineoplastic Combined Chemotherapy Protocols; C-Reactive Protein; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Inflammation; Lung Neoplasms; Vincristine | 1989 |
Effect of irradiation, cyclophosphamide, and etoposide (VP-16) on number of peripheral blood and peritoneal leukocytes in mice under normal conditions and during acute inflammatory reaction.
Topics: Animals; Cyclophosphamide; Disease Models, Animal; Etoposide; Granulocytes; Inflammation; Leukocyte Count; Leukocytes; Lymphocytes; Male; Mice; Monocytes; Peritoneal Cavity | 1989 |